Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Antares Vision Capital/Financing Update 2023

Nov 2, 2023

4255_rns_2023-11-02_faadc121-6543-465c-9297-c2d6347e890f.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

PRESS RELEASE

PROCEDURES AND EXERCISE RATIO OF ANTARES VISION WARRANTS

Travagliato (Brescia), 2 November 2023 – Antares Vision S.p.A. ("Antares Vision" or the "Company") announces that, pursuant to article 3 of the Regulation of "Antares Vision S.p.A. Warrants" (respectively, the "Warrants Regulation" 1 and the "Warrants"), the average monthly price for October 2023 is Euro 2.8883 (source FactSet, Average Monthly Price calculated as the arithmetic average of the official prices of ordinary Antares Vision S.p.A. shares on stock market trading days in October).

Therefore, since the average monthly price for October 2023, equal to Euro 2.8883, is lower than the strike price, equal to 9.50 euros, the warrants cannot be exercised during the month of November 2023.

Antares Vision, also, announces that in October the warrants could not be exercised. Consequently, the share capital of Antares Vision (Euro 169,456.78, divided into 69,121,137 ordinary shares, 250.000 Special Shares and 1,189,590 Performance Shares, with no nominal value indicated for any category) remained unchanged as well as the warrants outstanding (equal to 2,460,400).

For any further information, please refer to the Warrants Regulation available on the website of Antares Vision www.antaresvisiongroup.com - "Investors – Investor Relations – Warrant" section.

ABOUT ANTARES VISION GROUP

Antares Vision Group is an Italian multinational, listed on the STAR segment of Euronext and included in the Euronext Tech Leaders index, which is dedicated to leading tech companies with high growth potential. AV Group enables the digitalization of products and supply chains through traceability, inspection for quality control and integrated data management. It supports companies and institutions in ensuring. Through DIAMIND, the integrated ecosystem of solutions, the Group guarantees safety, quality, efficiency and sustainability of products (with inspection systems and machines) and end-to-end traceability across the supply chain (from raw materials to production, from distribution to the consumer, and vice versa), with integrated data management, boosted by artificial intelligence and able to be integrated with blockchains. AV Group operates in the Life Science sector (pharmaceutical products, biomedical devices and hospitals) and in the Fast-Moving Consumer Goods (FMCG) industry. It is the world leader in Track & Trace systems for pharmaceutical products, supplying major global manufacturers (over 50% of the top 20 multinationals) and numerous government authorities. AV Group recorded a turnover of Euro 223 million in 2022 (+25% YoY), operates in 60 countries, employs over 1,100 people, and boasts a network of over 40 international partners. More info: www.antaresvisiongroup.com

1 The terms indicated in this press release with a capital letter have the same meaning as those contained in the Warrants Regulation.

PRESS RELEASE

For further information

ISSUER

ANTARES VISION GROUP

ALESSANDRO BAJ BADINO (HEAD OF INVESTOR RELATIONS) TEL.: +39 030 72 83 500 E-MAIL: INVESTORS@ANTARESVISION.COM

DAVIDE ANTONIOLI (INVESTOR RELATOR) TEL.: +39 030 72 83 500 E-MAIL: INVESTORS@ANTARESVISION.COM